CP and COVID-19: COVID-19 is characterized by tissue injury as a result of alveolar capillary micro thrombi more prevalent in COVID patients leading to tissue hypoxia [18] and in our dataset raised levels of non-specific tissue injury marker i.e. LDH was observed in patients before CP treatment which sharply reduced after CP transfusion (Table 2 [10]).